Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
The Glioblastoma Multiforme (GBM) market is forecast to grow rapidly from $305m in 2012 to $583m in 2019 at a Compound Annual Growth Rate (CAGR) of 9.7%.
